Search

everythinglearnresearchcommunity

for

Search:↓

Patients with deficiency syndrome, especially qi deficiency, have a higher risk of type 2 heart attacks.

5α-Reductase inhibitors don't cause depression.

TSPO might help treat anxiety and depression.

Lithium treatment can cause increased hair shedding and hair loss in patients.

Skin and nail changes are common in patients with blood cancers undergoing chemotherapy, affecting their quality of life.

Finasteride boosts morphine's pain relief and prevents tolerance and withdrawal in rats.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Endogenous neurosteroids may set a baseline mood.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

Post-finasteride syndrome causes lasting sexual, mental, and physical issues, needing more research for solutions.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Certain medications, especially Paroxetine, Tamsulosin, and Finasteride, are linked to ejaculatory disorders.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

Finasteride may cause changes in dopamine-related genes, possibly leading to post-finasteride syndrome.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Addressing burnout and compassion fatigue in healthcare is crucial for improving job satisfaction and care quality.

Increasing TSPO in the brain reduces anxiety and depression.

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Eating disorders in gender dysphoria patients may be a coping mechanism for body image issues.